Cardiovascular

The Mediating Effect of Inflammatory Biomarkers in the Associations Between Sarcoidosis and Incident Ischemic Stroke: A Prospective Cohort Study.

TL;DR

Sarcoidosis independently increases the risk of ischemic stroke (HR = 1.335), with inflammatory biomarkers SII, lymphocyte percentage, and CRP serving as significant mediators, and shared molecular pathways involving ANKRD22, FCGR1A, and NOG genes identified through transcriptomic analysis.

Key Findings

Sarcoidosis was found to independently increase the risk of ischemic stroke in a large prospective cohort.

  • HR = 1.335 (95% CI: 1.002–1.779) from multivariable Cox regression analysis
  • The cohort included 452,382 UK Biobank participants followed for an average of 13.8 years
  • Sarcoidosis cases numbered n = 1,760
  • Sensitivity analysis using propensity score matching yielded consistent effect estimates (HR = 1.37)
  • Authors describe this as 'the first evidence of a significant association between sarcoidosis and ischemic stroke in a large cohort'

Three inflammatory biomarkers were identified as significant mediators in the association between sarcoidosis and ischemic stroke.

  • The systemic immune-inflammation index (SII) mediated 8.43% of the association
  • Lymphocyte percentage mediated 7.38% of the association
  • C-reactive protein (CRP) mediated 2.17% of the association
  • Mediation analysis was used to evaluate the role of each inflammatory marker

Transcriptomic analysis identified three genes differentially expressed in both sarcoidosis and ischemic stroke.

  • The three overlapping genes identified were ANKRD22, FCGR1A, and NOG
  • Transcriptomic profiles were sourced from the GEO database, specifically datasets GSE58294 and GSE19314
  • Differential gene expression, GO and KEGG pathway enrichment, and protein-protein interaction network analyses were performed
  • The TGF-β/BMP signaling pathway and immune regulatory network were highlighted as shared molecular underpinnings

The study integrated multi-omics approaches combining large-scale epidemiological data with transcriptomic profiling to explore shared molecular frameworks between sarcoidosis and ischemic stroke.

  • UK Biobank data (n = 452,382) were combined with transcriptomic profiles from the GEO database
  • Analytical methods included multivariable Cox regression, mediation analysis, differential gene expression, GO and KEGG pathway enrichment, and protein-protein interaction networks
  • Sarcoidosis is characterized by granulomatous inflammation across multiple systems
  • The study follow-up averaged 13.8 years

Have a question about this study?

Citation

Bai Z, Shao W, Huang X, Tan S, Ling Y, Yuan S, et al.. (2026). The Mediating Effect of Inflammatory Biomarkers in the Associations Between Sarcoidosis and Incident Ischemic Stroke: A Prospective Cohort Study.. Brain and behavior. https://doi.org/10.1002/brb3.71350